(Q41451309)

30 September 2017

1 reference

title

Can antimicrobial activity be sustained? An appraisal of orally administered drugs used for respiratory tract infections (English)

1 reference

respiratory tract infection

30 September 2017

main subject

1 reference

Jones RN

1 reference

30 September 2017

publication date

1 January 1997

1 reference

Diagnostic Microbiology and Infectious Disease

30 September 2017

published in

1 reference

30 September 2017

1 reference

30 September 2017

issue

1-2

1 reference

30 September 2017

page(s)

21-28

1 reference

Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Detection of quinolone resistance in Haemophilus spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Lower respiratory tract infection due to ciprofloxacin resistant Moraxella catarrhalis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Quinolone resistant Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Resistance to antimicrobial drugs--a worldwide calamity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Global Surveillance of Antibiotic Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. The Alexander Project

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

Moraxella catarrhalis: pathogenic significance in respiratory tract infections treated by community practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900118-1

7 January 2021

10.1016/S0732-8893(97)00118-1

Identifiers

DOI

1 reference

30 September 2017

1 reference